Exploring anti-IL6 receptor monoclonal antibody tocilizumab in neuromyelitis optica

被引：0
|
作者：
Araki, M. [1 ]
Matsuoka, T. [1 ]
Aranami, T. [1 ]
Nakamura, M. [1 ]
Okamoto, T. [1 ]
Murata, M. [1 ]
Miyake, S. [1 ]
Yamamura, T. [1 ]
机构：
[1] Natl Ctr Neurol & Psychiat, Tokyo, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：326 / 327
页数：2
相关论文
共 50 条
  • [1] Immunomodulatory effect of anti-IL6 receptor monoclonal antibody tocilizumab in patients with neuromyelitis optica
    Matsuoka, T.
    Chiba, A.
    Aranami, T.
    Araki, M.
    Nakamura, M.
    Miyake, S.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 463 - 464
  • [2] Clinical efficacy of anti-IL-6 receptor monoclonal antibody tocilizumab for the treatment of neuromyelitis optica
    Araki, M.
    Matsuoka, T.
    Aranami, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 947 - 947
  • [3] Clinical Efficacy of Anti-IL-6 Receptor Monoclonal Antibody Tocilizumab in Patients with Neuromyelitis Optica
    Araki, Manabu
    Matsuoka, Takako
    Aranami, Toshimasa
    Nakamura, Masakazu
    Okamoto, Tomoko
    Murata, Miho
    Miyake, Sachiko
    Yamamura, Takashi
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 911 - 912
  • [4] Clinical efficacy of anti-IL-6 receptor monoclonal antibody tocilizumab in three patients with neuromyelitis optica
    Araki, M.
    Aranami, T.
    Matsuoka, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 417 - 417
  • [5] How does anti-IL-6 receptor monoclonal antibody tocilizumab treatment ameliorate neuromyelitis optica?
    Matsuoka, T.
    Araki, M.
    Yamaguchi, H.
    Sato, W.
    Miyamoto, K.
    Kusunoki, S.
    Gold, R.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 1000 - 1001
  • [6] Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
    Araki, Manabu
    Aranami, Toshimasa
    Matsuoka, Takako
    Nakamura, Masakazu
    Miyake, Sachiko
    Yamamura, Takashi
    [J]. MODERN RHEUMATOLOGY, 2013, 23 (04) : 827 - 831
  • [7] Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
    Araki, Manabu
    Matsuoka, Takako
    Miyamoto, Katsuichi
    Kusunoki, Susumu
    Okamoto, Tomoko
    Murata, Miho
    Miyake, Sachiko
    Aranami, Toshimasa
    Yamamura, Takashi
    [J]. NEUROLOGY, 2014, 82 (15) : 1302 - 1306
  • [8] Anti-IL6 Receptor Monoclonal Antibody Therapy in NMOSD
    Araki, Manabu
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 436 - 436
  • [9] Radiological Evaluation of Systemic Juvenile Idiopathic Arthritis Treated with Tocilizumab, An Anti-IL6 Receptor Monoclonal Antibody.
    Aoki, Chie
    Inaba, Yutaka
    Imagawa, Tomoyuki
    Miyamae, Takako
    Mori, Masaaki
    Saito, Tomoyuki
    Yokota, Shumpei
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1031 - S1032
  • [10] Anti-IL6 Receptor Monoclonal Antibody Therapy in NMO. Takashi Yamamura (Japan)
    Yamamura, Takashi
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 396 - 396
12345